Bausch Health Cos Inc. (NYSE:BHC) Shares Sold by Intact Investment Management Inc.

Intact Investment Management Inc. reduced its position in Bausch Health Cos Inc. (NYSE:BHC - Free Report) by 29.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 185,200 shares of the company's stock after selling 76,100 shares during the period. Intact Investment Management Inc. owned approximately 0.05% of Bausch Health Cos worth $1,201,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Maple Rock Capital Partners Inc. increased its position in shares of Bausch Health Cos by 156.7% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 5,300,000 shares of the company's stock worth $42,718,000 after acquiring an additional 3,235,100 shares during the last quarter. Compass Rose Asset Management LP increased its holdings in Bausch Health Cos by 366.7% during the 4th quarter. Compass Rose Asset Management LP now owns 2,100,000 shares of the company's stock worth $16,926,000 after purchasing an additional 1,650,000 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in shares of Bausch Health Cos by 46.3% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,770,793 shares of the company's stock valued at $38,501,000 after purchasing an additional 1,510,445 shares in the last quarter. O Shaughnessy Asset Management LLC raised its position in shares of Bausch Health Cos by 989.1% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 611,890 shares of the company's stock valued at $4,940,000 after purchasing an additional 555,709 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its stake in shares of Bausch Health Cos by 1,761.5% during the 4th quarter. Renaissance Technologies LLC now owns 495,172 shares of the company's stock valued at $3,991,000 after buying an additional 468,572 shares during the last quarter. 78.65% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director John Paulson acquired 1,029,098 shares of the company's stock in a transaction that occurred on Wednesday, June 11th. The shares were acquired at an average price of $5.24 per share, with a total value of $5,392,473.52. Following the acquisition, the director now directly owns 28,222,267 shares in the company, valued at approximately $147,884,679.08. The trade was a 3.78% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In the last 90 days, insiders have purchased 6,352,667 shares of company stock valued at $35,870,767. Insiders own 8.05% of the company's stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Royal Bank Of Canada lifted their price target on shares of Bausch Health Cos from $8.50 to $10.00 and gave the stock a "sector perform" rating in a research note on Friday, May 2nd. Wall Street Zen lowered shares of Bausch Health Cos from a "buy" rating to a "hold" rating in a report on Saturday, May 10th. One research analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $7.42.

Bausch Health Cos Stock Up 0.7%

BHC stock traded up $0.05 during trading on Thursday, hitting $6.43. 2,318,540 shares of the company's stock traded hands, compared to its average volume of 2,620,671. The stock has a market capitalization of $2.38 billion, a price-to-earnings ratio of -58.41 and a beta of 0.28. Bausch Health Cos Inc. has a 52 week low of $3.96 and a 52 week high of $9.85. The stock has a fifty day moving average price of $5.11 and a two-hundred day moving average price of $6.31.

Bausch Health Cos Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.